Marina Frimer, MD | Northwell Health

Dr. Marina Frimer, MD

Claim this profile

Northwell Health

Studies Uterine Cancer
Studies Endometrial Adenocarcinoma
6 reported clinical trials
28 drugs studied

Area of expertise

1Uterine Cancer
Marina Frimer, MD has run 2 trials for Uterine Cancer. Some of their research focus areas include:
Stage III
Stage IV
MMR negative
2Endometrial Adenocarcinoma
Marina Frimer, MD has run 2 trials for Endometrial Adenocarcinoma. Some of their research focus areas include:
MMR negative
MSI positive
Stage I

Affiliated Hospitals

Image of trial facility.
Northwell Health
Image of trial facility.
Northwell Health/Center For Advanced Medicine

Clinical Trials Marina Frimer, MD is currently running

Image of trial facility.

Targeted Therapy

for Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting1 award Phase 29 criteria
Image of trial facility.

Surgical Procedures

for Reducing Ovarian Cancer Risk

This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
Recruiting1 award N/A

More about Marina Frimer, MD

Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Marina Frimer, MD has experience with
  • Pembrolizumab
  • Niraparib
  • Everolimus
  • Levonorgestrel-Releasing Intrauterine System
  • Brachytherapy
  • External Beam Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Marina Frimer, MD specialize in?
Is Marina Frimer, MD currently recruiting for clinical trials?
Are there any treatments that Marina Frimer, MD has studied deeply?
What is the best way to schedule an appointment with Marina Frimer, MD?
What is the office address of Marina Frimer, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security